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Abstract
Background: Structural changes have been found predominantly in the frontal cortex and in the striatum in
children and adolescents with Gilles de la Tourette syndrome (GTS). The influence of comorbid symptomatology is
unclear. Here we sought to address the question of gray matter abnormalities in GTS patients with co-morbid
obsessive-compulsive disorder (OCD) and/or attention deficit hyperactivity disorder (ADHD) using voxel-based
morphometry (VBM) in twenty-nine adult actually unmedicated GTS patients and twenty-five healthy control
subjects.
Results: In GTS we detected a cluster of decreased gray matter volume in the left inferior frontal gyrus (IFG), but
no regions demonstrating volume increases. By comparing subgroups of GTS with comorbid ADHD to the
subgroup with comorbid OCD, we found a left-sided amygdalar volume increase.
Conclusions: From our results it is suggested that the left IFG may constitute a common underlying structural
correlate of GTS with co-morbid OCD/ADHD. A volume reduction in this brain region that has been previously
identified as a key region in OCD and was associated with the active inhibition of attentional processes may reflect
the failure to control behavior. Amygdala volume increase is discussed on the background of a linkage of this
structure with ADHD symptomatology. Correlations with clinical data revealed gray matter volume changes in
specific brain areas that have been described in these conditions each.
Keywords: Gilles de la Tourette syndrome, Voxel-based morphometry, Inferior frontal gyrus, Amygdala, Obsessive-
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Background
Gilles de la Tourette syndrome (GTS) is a complex
chronic motor and vocal tic disorder with childhood
onset. However, the majority of patients, in addition, suf-
fer from different comorbid disorders, most often obses-
sive-compulsive disorder (OCD) and attention deficit
hyperactivity disorder (ADHD) [1,2]. On average, 20-60%
of all GTS patients have comorbid OCD, while about
50% suffer from ADHD [3]. In contrast, GTS “only” -
without any comorbidity - occurs in only 10 to 15% [4,5].
Previous structural imaging studies investigating gray and
white matter abnormalities in GTS revealed conflicting
results. It has been suggested that these inconsistent data
are mainly related to differences in patients’ age, gender,
handedness, medication status, comorbidities, imaging
techniques, and analysis strategy. Despite these discre-
pancies, there is substantial evidence that structural
alterations in several brain regions are indeed related to
the pathology of GTS (for an overview, see also [6]).
Most of these changes corroborate the hypothesis of
alterations in cortico-striato-thalamo-cortical circuits
[7-10]. In particular, there is evidence for reduced basal
ganglia volumes [10], a volume decrease of the amygdala
in adults [11,12], but increased volumes in children [12],
and an increase of gray matter volumes in the mesence-
phalon [13,14] and in dorsolateral prefrontal regions in
children, but not in adults [9]. In a treatment-naïve boys-
only group without comorbidities, increased volumes of
the putamen bilaterally and the corpus callosum (subre-
gion 3) were found [15]. A study using diffusion tensor
imaging (DTI), a method that allows conclusions about
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properties [16], provided additional evidence for white
matter abnormalities of somatosensory pathways in GTS
adults [17]. By means of high-resolution structural MRI,
recent studies showed cortical thinning in large areas of
the frontal and parietal lobe in children with GTS [18],
and reduced cortical thickness in motor, premotor, pre-
frontal and lateral orbitofrontal areas in adult patients
suffering from GTS [19]. Available morphometric studies
strongly suggest that structural patterns in children are
quite opposite to those in adults indicating the occur-
rence of neuroplastic developmental processes during the
course of the disease. In line with this assumption are
findings of increased prefrontal volumes with associated
decreased size of the corpus callosum in GTS children
[20,21] - which are thought to reflect compensatory
mechanisms in order to facilitate suppression of tics
[9,22] - but decreased dorsal prefrontal and increased
corpus callosum volumes in GTS adults which are possi-
bly associated with symptom persistence into adulthood
[9,21,23]. In a recent study from our group, we used
voxel-based morphometry (VBM) and magnetization
transfer imaging (MTI) to investigate actually unmedi-
cated adult GTS “only” patients and found structural dif-
ferences predominantly in prefrontal areas, stressing a
more fronto-striatal dysfunction rather than a distinct
basal ganglia involvement [24].
VBM has been proven to be a powerful method for the
in vivo study of human brain structures [25,26]. This
technique relies on the segmentation of magnetic reso-
nance (MR) images into different tissue types (e.g. gray
matter, white matter, and cerebrospinal fluid) using prob-
ability measures based on image intensities [27]. It is a
semi-automated, unbiased technique that is based on a
voxel-wise analysis without the need for a priori hypoth-
eses. Here we sought to address the question of gray mat-
ter abnormalities in adult GTS patients with comorbid
OCD and/or ADHD compared to healthy controls using
VBM. More specifically, we applied a sophisticated com-
putational image analysis approach both to compare
regional volumes of gray matter throughout the brain
[28] and to test whether there is a common pattern of
structural brain alteration occurring in patients with GTS
plus OCD as well as in those with comorbid ADHD.
Results
Clinical assessments
There were no differences in sex, age, and handedness
between GTS patients and normal controls. Comparing
clinical parameter, the IQ (MWT-B) was found signifi-
cantly lower in GTS patients compared to healthy controls
(t = 2.3; df = 51; p = 0.03). However, none of the patients
had an IQ below 92. Results of clinical assessments regard-
ing severity of tics, OCD, ADHD, depression, and anxiety
differed significantly between GTS patients and normal
controls (see Table 1).
Differences in GM volumes between patients with GTS
and healthy control subjects
We detected a cluster of decreased gray matter volume
in the left inferior frontal gyrus (IFG) in GTS patients
compared to healthy controls (more details are provided
in Table 2). The peak voxel of this cluster of reduced
gray matter density was located in the pars triangularis
of the inferior frontal cortex. The cluster itself extends
into pars orbitalis.
Table 1 Demographical and clinical characteristics
GTS plus (n = 8) GTS- OCD (n = 17) GTS-ADHD (n = 4) Healthy control group (n = 24) p
Age Mean 30.7 (9), range 18-49 Mean 30.6 (10.9), range 18-59 .97
Sex male male -
Handedness right right -
IQ 105.6 (13.3) 114 (15) .03
RVTRS 8 (4.6) 0 -
YGTSS 35.7 (17.6) 0 -
Y-BOCS obsessions 6.5 (5.5) 10.5 (6.2) 0 0 -
Y-BOCS compulsions 9.6 (5.4) 10.4 (4.4) 0 0 -
WURS-K 38 (9.2) 19.9 (9) 29.3 (10.2) 13.5 (9.7) .001
CAARS 5.6 (2.4) 4.9 (1.6) 4.3 (1.1) 4 (1.6) .04
ADHD symptom list part 1 7.2 (1.5) 2.6 (2.1) 6.3 (2) 1 (1.8) .003
ADHD symptom list part 2 6.2 (2.4) 0.7 (1.1) 5 (2.6) 1 (1.3) .001
BDI 13.2 (9.1) 4.2 (3.6) 1 (1.7) 1.9 (2.4) .001
STAI- 1 57.6 (7.8) 39.8 (10.5) 27.3 (1.5) 29.5 (6.3) .001
STAI- 2 55 (10.2) 43.2 (12.7) 25.7 (5.5) 31 (8) .003
All additional values in parenthesis are standard deviations.
Wittfoth et al. BMC Neuroscience 2012, 13:17
http://www.biomedcentral.com/1471-2202/13/17
Page 2 of 10In order to be sure that the IQ score differences between
groups have not confounded our results, we have con-
ducted a separate analysis including IQ scores as covari-
ates. We still found a cluster of reduced gray matter
volume density in the left IFG. Thus, we are sure that the
significant, but small IQ group differences cannot explain
differences of gray matter volumes between groups.
As can be seen in Figure 1, the differentiation of para-
meter estimates of the different GTS subgroups and nor-
mal controls revealed that the decrease in gray matter in
t h el e f tI F Gw a sm a i n l ye v o k e db yt h o s et w oG T Ss u b -
groups suffering from comorbid OCD (GTS + OCD and
GTS “plus”). IFG gray matter values of GTS patients with
comorbid ADHD (but without OCD) seem to be com-
parable to healthy controls. However, on the background
of the very small size of four patients (GTS + ADHD)
and in order to test this assumption, we excluded this
group from the following analysis. For the comparison of
the remaining two subgroups which had comorbid OCD
symptomatology (GTS + OCD and GTS “plus”)w i t h
healthy controls, we found a more pronounced cluster in
the left IFG (-34, 42, 7; cluster size 464 voxels, t-value
4.64). There were no regions demonstrating volume
increases in GTS patients for this comparison.
Differences in GM volumes between GTS patient
subgroups
In order to show that GTS subgroups with ADHD
comorbidity (n = 8 + 4) are significantly different
compared to the GTS group without ADHD comorbid-
ity (GTS and OCD; n = 17) in regard to gray matter
volumes, we directly compared these groups. By com-
paring the subgroups with comorbid ADHD (GTS +
ADHD and GTS “plus”) with patients suffering from
Tourette with OCD symptomatology only (GTS +
OCD), we found an increase of gray matter density in
the left amygdala. This cluster was also significant in
comparison to healthy controls, indicating differences
due to pathology. We found no significant clusters of
volume reductions here.
GM volumes: correlations with clinical scores
Correlations between clinical scores and cortical gray
matter volumes in patients suffering from GTS are pre-
sented in Figure 2 and Table 3. By separately conducting
multiple regression analyses for different symptoms (tics
(YGTSS and RVTRS), OCD (Y-BOCS), and ADHD
(symptom checklist, CAARS, WURS-K)), we successively
excluded clinical scores that decreased the fit of our
model. All following results are significant at our initial
p < 0.001, and represent multiple regression models best
predicting GM values of GTS patients.
Tic severity measured with the RVTRS correlated
negatively with the volume of the right superior frontal
gyrus (r = -0.65) and the left insula (r = -0.63). No
regions showed a positive correlation with the RVTRS.
The left postcentral gyrus showed a negative correla-
tion with the Y-BOCS scores assessing obsessions (r =
Table 2 Regional gray matter volume differences in patients suffering from GTS compared to controls.
Anatomical area L/R Cluster size T-value x y z
Tourette GM volume decrease compared to healthy controls
IFG (BA 47/12) L 144 3.44 36 38 3
GM volume increase of GTS+ADHD and GTS+ADHD+OCD compared to GTS+OCD
Amygdala L 181 4.65 -33 -2 -20
Listed are all regions that survived a cluster size extent threshold of k > 99 voxels. Coordinates refer to the point of maximal change in MNI space
Figure 1 Decreases of gray matter volumes in GTS patients. Overlay of gray matter decreases on the SPM8 gray matter template illustrating
where group comparisons revealed significantly reduced gray matter volume differences in GTS groups compared to healthy controls.
Additionally, extracted gray matter values of inferior frontal gyrus for specific patient subgroups and controls are shown. The display is presented
in neurological convention (R = R; L = L)
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Page 3 of 10-0.63) and compulsions (r = -0.69) in patients with GTS.
No regions showed a positive correlation with the
Y-BOCS.
By conducting multiple regression analyses including
ADHD scales (symptom checklist inattention and
hyperactivity, CAARS, WURS-K), we found a positive
correlation with gray matter volumes of the left (inatten-
tion: r = 0.5; hyperactivity: r = 0.7) and right putamen
(inattention: r = 0.6; hyperactivity: r = 0.63) while no
negative correlations could be observed.
Figure 2 Selected cortical regions showing significant correlations with test scores in GTS patients. The left side shows cortical regions
that were significantly correlated with the RVTRS (upper), Y-BOCS (middle), and ADHD (lower) scores (symptom checklist inattention (1) and
hyperactivity (2)). The crosshair was laid on the most significant voxel. Additionally, scatterplots displaying the correlation between the clinical
score (x-axis) against the globally scaled gray matter values (y-axis), and parameter estimates plotted as bar graphs are provided. All correlations
were significant at our initial p < 0.001
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The present study identified a common pattern of gray
matter brain tissue alteration in actually unmedicated
adult patients with GTS and comorbid OCD and/or
ADHD characterized by left inferior frontal gyrus
decreases of GM volumes. There were no significant dif-
ferences between healthy controls and GTS patients con-
cerning a GM volume increase. Based on our results, we
suggest that the left IFG may constitute a common under-
lying neurological correlate of GTS with comorbid OCD
and/or ADHD. As can be seen in Figure 1, gray matter
volume reductions of the left IFG in the whole group of
GTS patients are predominantly observed in the sub-
groups of GTS patients with comorbid OCD. This possibly
reflects the failure to control behavior and may be a key
feature of persistent GTS and OCD in adults. The finding
of left IFG decreases of GM volumes is in line with data
from recent studies [29] including our own examining
patients with GTS “only” and demonstrating volume
reductions predominantly in different frontal areas [24].
Thus, it is not surprisingly that in the present study
volume reduction of the left IFG was pronounced in GTS
patients with comorbid OCD/ADHD which suggests an
additive effect. In particular, the left IFG has previously
been associated as a key region for OCD [30]. Together
with the inferior parietal cortex it serves as a network
responsible for the active inhibition of attentional pro-
cesses. Additionally, this network has been associated with
voluntary shifts of attention across sensory modalities [31].
The precise location of this region is heterogeneous across
studies, as it includes the most orbital part of the IFG and
extends into the lateral orbitofrontal gyrus (sometimes
used as synonyms). In OCD patients, functional alterations
of this region have been observed, and a recent meta-
analysis could associate these functional alterations
to structural abnormalities [32]. However, the neuronal
mechanisms are still unknown, and even the direction
of the functional-structural relationship is controversial.
Table 3 Brain regions showing significant correlations with clinical scores
Anatomical area L/R Cluster size T-value x y z
GM correlations with RVTRS
Premotor cortex R 157 4.58 16 6 55
Insula L 255 4.41 -31 6 4
Precuneus R 185 4.07 3 -57 31
Posterior cingulate cortex R 101 4.02 10 -40 25
IFG R 96 3.87 30 28 -4
GM correlations with Y-BOCS (total score)
Postcentral gyrus L 374 5.75 -38 -39 60
Superior parietal lobule R 184 4.96 15 -67 52
Occipital pole R 449 4.34 22 -100 9
GM correlations with ADHD scores (Symptom checklist, CAARS, WURS-K)
Putamen L 433 4.73 -26 9 -9
R 503 4.94 20 6 -12
GM correlations with BDI
Anterior cingulate cortex L 202 4.44 2 14 18
Middle temporal gyrus L 90 4.34 -51 -49 -2
Lateral occipitotemporal gyrus R 90 4.30 39 -48 -17
GM correlations with STAI
Anterior cingulate cortex L 1423 5.07 -16 47 7
Insula R 383 5.01 48 -3 1
L 558 4.91 -42 9 -3
Middle occipital gyrus L 135 4.60 -39 -61 24
Lateral occipitotemporal gyrus R 105 4.47 36 -52 -8
Midcingulate cortex L 149 4.35 -3 -27 40
Middle frontal gyrus R 158 4.19 26 58 1
L 141 4.14 -30 60 1
Superior parietal lobule R 278 4.12 0 -64 46
Medial frontal gyrus L 132 3.91 -6 35 42
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by van den Heuvel and colleagues [33], the lateral orbito-
frontal cortex was found to be reduced in OCD patients
compared to healthy controls, whereas a more recent
meta-analysis, in which functional and structural findings
were combined, showed greater gray matter density of the
lateral orbitofrontal cortex in OCD [34]. However, by
using a different voxel-based meta-analytic method called
signed differential mapping, Radua and Mataix-Cols [35]
could not find any structural abnormalities of patients suf-
fering from OCD in this area. They reported an associa-
tion of gray matter volume increases in the basal ganglia
with symptom severity in OCD.
But are there any functional changes of the left IFG in
G T S ?W ea r ea w a r eo fo n l yas i n g l eP E T - s t u d y[ 3 6 ]
reporting an abnormal positive coupling between the basal
ganglia and the lateral orbitofrontal cortex. In fact, thirteen
out of eighteen patients included in this study had comor-
bid OCD symptomatology suggesting that OCD pathology
is a main factor of alterations in this frontal region. Our
data corroborate the assumption that compensatory neu-
roplastic processes in terms of frontal cortex hypertrophy
- that might help to compensate tics [29] as can be seen in
GTS adolescents [22] - are absent or even reversed in
adults with persistent tic disorders [37].
Our results of a comparison of the GTS subgroups with
ADHD comorbidity to the GTS group without ADHD
comorbidity (GTS and OCD) revealed a volume increase
of the left amygdala which could also be observed in com-
parison to healthy controls. Structural alterations of the
amygdala -gray matter volume increase in particular [12] -
have been previously associated with compensatory
mechanisms in GTS [38]. The findings in pure ADHD
adult groups have been equivocal so far [39]. In children
with GTS and comorbid ADHD symptomatology, a linkage
between amygdalar volume reductions has been reported
[11]. It seems reasonable to assume that our finding of gray
matter volume increase in the left amygdale reflects long-
term structural mechanisms in order to compensate a
delay in cortical maturation during childhood [40].
VBM analyses reflect a number of anatomical features,
including gray matter alterations and shifts in gyral or
sulcal anatomy. Therefore, it can be speculated that GM
volume decreases observed in this study might be the
consequence of malformated cortical development, such
as abnormal neuronal migration. Future studies using
different volumetric measurements such as an estima-
tion of cortical thickness may further contribute to the
underlying structural differences in GTS [19,41].
Lack of findings in previously reported regions and
limitations of the study
We failed to detect group differences in regions pre-
viously associated with GTS pathology including the
basal ganglia [7-10] and the mesencephalon [13,14].
These discrepancies may reflect sample characteristics
(since we included only actually unmedicated adults
GTS patients with comorbid OCD/ADHD) and different
methodological approaches. For example, Ludolph [8]
and Garraux [14] used predefined regions of interest
and subsequently conducted small volume corrections.
This analysis strategy assumes stationary smoothness,
which may not even be appropriate for VBM [42]. Addi-
tionally, it has been discussed that larger sample sizes
(including up to 70-90 subjects) may be a prerequisite
in order to detect volume differences of small subcorti-
cal structures [43]. Thus, our failure to detect significant
differences in these particular regions does not necessa-
rily prove that these regions are indeed unaffected.
A limitation of the study was the small subgroup of
only 4 patients with comorbid ADHD (without OCD).
When excluding this subgroup from additional analyses,
differences between GTS patients and controls even
increase strengthening our assumption that GM volume
reduction in the inferior frontal gyrus are mainly based
on the presence of comorbid OCD. However, future
structural studies including larger samples of patients
with comorbid ADHD are needed to better clarify the
impact of comorbid ADHD.
Although the group of patients and the control group
were not comparable in regard to IQ, we do not think
that group differences can be explained by these small
IQ differences, since - to the best of our knowledge -
there are no VBM studies available reporting morpholo-
gical alterations on the basis of small group differences
in intelligence. Our results are in line with recent find-
ings in children demonstrating that IQ scores in patients
with GTS “plus” (with comorbidities) are slightly
reduced compared to healthy [44].
Although all patients included in this study were
unmedicated for at least 6 months prior to MRI ima-
ging, some patients were medicated with typical or aty-
pical antipsychotics before. In patients with Tourette
syndrome, it has been demonstrated that neuroleptic
medication increases both caudate and globus pallidus
volumes [10]. Because in patients with schizophrenia it
has been demonstrated that medication effects are
reversible [45,46], we speculate that in the present study
possible influences of antipsychotic medication on brain
volumes can be excluded. However, to the best of our
knowledge, in patients with GTS no longitudinal studies
are available investigating neuroleptic-induced volume
changes after withdrawal from medication.
Gray matter volume correlations with clinical scores
We found several significant correlations between GM
volumes and different clinical scores. Tic severity
(RVTRS) correlated negatively with GM volumes of
Wittfoth et al. BMC Neuroscience 2012, 13:17
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Although, video-based tic ratings represent only a short
period of time, they are regarded as the most objective
tic measurement. Since in adult patients, spontaneous
tic fluctuations are less marked compared to children, it
can be speculated that the RVTRS indeed represents tic
severity in an individual patient.
This result is in line with recent morphological [47]
and functional [48,49] findings in GTS patients empha-
sizing an involvement of the insula in tic generation.
Furthermore, in people with persistent and routine
habits an involvement of this brain area has been found
supporting the hypothesis of an insula-striatal neural
interplay during the preference of default behavior [50].
The premotor cortex has also been described before as
a brain region that is involved in GTS pathology
demonstrating abnormal metabolic networks [51]. Addi-
tionally, it was recently suggested that cortical thinning
in premotor areas is correlated with more complex tics
in GTS adults [19].
In line with findings of a recent study in patients with
“pure” OCD [52], we found a negative correlation
between the severity of OCD (Y-BOCS) and the left
postcentral gyrus. In “pure” OCD an involvement of dif-
ferent brain areas including both the (orbito-) frontal
cortex and the anterior cingulate cortex, as well as sub-
cortical structures such as the thalamus and caudate
nucleus has been suggested [53,54]. However, there is
evidence that in different symptom dimensions of OCD
different brain networks might be involved [55]. For
example, functionally decreased activity in the left post-
central gyrus has been found in patients with obses-
sions/checking rituals but not in those with cleanliness/
washing rituals [53]. It is well known that in patients
with GTS plus OCD a different OCD symptom subtype
occurs compared to patients with “pure” (tic-free) OCD:
While obsessions/checking rituals are relatively common
in GTS patients, aggressive repetitive thoughts, contami-
nation worries and washing behaviours are rare [56].
Thus, our finding of a negative correlation between
OCD severity and GM volume of the left postcentral
gyrus further supports an involvement of this brain area
in the pathology of OCD in GTS patients. In addition, it
can be speculated that comparable brain areas are
involved in those patients with the OCD subtype obses-
sions/checking rituals and GTS patients with comorbid
OCD suggesting a common underlying pathophysiology.
In contrast, we found a positive correlation between
the severity of ADHD (assessed by the symptom check-
list, CAARS, and WURS-K) and bilateral GM volumes
in the putamen. This finding is in line with results
obtained from recent MRI studies in children with
“pure” ADHD consistently demonstrating an involve-
ment of the putamen [57,58] with unilateral or bilateral
GM volume reduction in this brain area. Structural stu-
dies involving adults with ADHD are limited and
resulted in contradictory data (for an overview see [59]).
It can be speculated that differences regarding GM
volume sizes in children with ADHD compared to
adults with ADHD are related to developmental neuro-
plastic processes. Comparable findings with opposite
volume changes in children and adults have been
demonstrated in patients with GTS [24,29]. Our results
further support the hypothesis that the basal ganglia,
and in particular the putamen, are involved in the
pathophysiology of ADHD, since this region has been
associated with diverse cognitive functions (e.g., lan-
guage, learning and memory, attention and control of
behavioural responses) [59]. In addition, our finding of a
correlation between ADHD severity and GM volume of
the putamen in patients suffering from GTS is in line
with the assumption that the coexistence of ADHD and
GTS represents an additive rather than an interactive or
phenotype model [60].
Conclusions
By means of VBM we found a gray matter reduction in
the left IFG in GTS patients with comorbid OCD/
ADHD compared to healthy controls. Furthermore, the
volume of the left amygdala was found to be increased
in the subgroup of GTS patients with ADHD sympto-
matology. From our data it is suggested that the coexis-
tence of tics and ADHD and/or OCD represents an
additive model, since in patients with GTS “plus” sever-
ity of tics, ADHD, and OCD each correlated with those
brain regions (left insula and the right superior frontal
cortex, putamen, left postcentral gyrus, respectively) that




Forty-one adult (≥ 18 years) male patients with the diag-
nosis of GTS according to DSM IV-TR criteria were
scanned for this study. All patients suffered either from
comorbid OCD, ADHD, or both. All patients were actu-
ally unmedicated for at least six months before entering
the study. For the diagnosis of ADHD we used both, a
psychiatric examination and different self-rating scales
including the DSM-IV symptom check-list for ADHD
[61] consisting of 18 screening questions for inattention
and hyperactivity (9 questions each), the Conners’ Adult
ADHD Rating Scales (CAARS; Self report - long version)
[62], consisting of 66 items assessing for inattention/
memory problems, impulsivity/emotional lability, hyper-
activity/restlessness, and problems with self-concept, and
the Wender-Utah-Rating-Scale short form (WURS-K)
[63], a 25-item-self-rating for the retrospective diagnosis
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a psychiatric evaluation as well as the German versions of
the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
[64], a measurement for OCD containing a checklist for
specific obsessions and compulsions as well as a rating
scale separately for obsessions and compulsions (scoring
for expenditure of time, interference, distress, resistance,
degree of control). Tic severity was rated using the Yale
Global Tic Severity Scale (YGTSS) [65], consisting of rat-
ings separately for motor and vocal tics concerning num-
ber, frequency, intensity, complexity, and interference,
plus an overall TS impairment rating as well as the modi-
fied Rush Video-based Tic Rating Scale (RVTRS) [66].
The RVTRS is based on a 10-minute film protocol
including near and far body views rating on five disability
categories (number of body areas, frequency of motor
tics, frequency of vocal tics, severity of motor tics, and
severity of vocal tics). In addition, IQ was assessed with
the MWT-B (Mehrfachwahl-Wortschatz-Intelligenztest),
a test in which a real word among four pseudo-words has
to be identified [67]. In order to assess depression and
anxiety, Beck Depression Inventory-II (BDI), consisting
of 21 questions about the subject’s feeling in the last
week) [68], and STAI (State-Trait Anxiety Inventory),
consisting of 40 questions for measuring both “state anxi-
ety” and “trait anxiety” in adults [69] were used.
None of the patients had a history of head trauma, epi-
lepsy, brain surgery, systemic illness, drug or alcohol
abuse, or any other significant comorbid disorder. In all
patients a neurological and psychiatric examination was
performed by one of the authors (KR MV) who is experi-
enced in the diagnosis of TS, OCD, and ADHD. Twenty-
five healthy control subjects individually matched for age
and gender were enrolled in this study. Exclusion criteria
were the same as for the patients’ group. Healthy controls
were interviewed and examined in the same way as
patients. Handedness for all participants was assessed
with the Edinburgh Handedness Inventory [70]. The
study was approved by the local ethical standards com-
mittee and was carried out in accordance with the
declaration of Helsinki. All participants gave written
informed consent after all procedures had been fully
explained to them before entering the study.
Of 66 participants included in the study, data sets of 53
(n = 29 GTS patients, n = 24 healthy controls) partici-
pants were used for further analyses. Data sets of 13 par-
ticipants did not survive our strict image quality control
due to different reason: poor image quality due to exces-
sive movement artifacts (n = 9 GTS patients), anatomical
abnormalities that prevent reliable and accurate spatial
normalization (n = 1 healthy control), and claustrophobia
leading to incomplete measurements (n = 3 GTS
patients). Demographic and clinical parameters are sum-
marized in Table 1. For further analyses patients were
divided into three different subgroups according to their
kind and number of comorbid disorders: (1) GTS “plus”
(with comorbid OCD and ADHD, n = 8), (2) GTS-OCD
(n = 17), and (3) GTS-ADHD (n = 4).
MR image acquisition
All MRI scans were obtained at 1.5 Tesla General Electric
Signa Horizon LX (General Electric Company, Milwau-
kee, WI, USA). A high-resolution three-dimensional T1-
weighted spoiled gradient recalled echo (SPGR) sequence
generated 124 contiguous sagittal slices (TR = 24 ms;
TE = 8 ms; flip angle = 30°; voxel dimensions 0.97 ×
0.97 × 1.5 mm
3).
Voxel-based GM volume analysis
Data were processed and examined using the SPM8 soft-
ware (Wellcome Department of Imaging Neuroscience
Group, London, UK; http://www.fil.ion.ac.uk/spm, where
we applied VBM standard routines and default parameters
implemented in the VBM8 toolbox (r347) http://dbm.
neuro.uni-jena.de/vbm.html running under the MATLAB
7.10 (R2010a; Mathworks, Sherbon, Massachusetts) envir-
onment. Voxel-based morphometry is a whole-brain,
unbiased, semi-automated technique for characterizing
regional cerebral differences in structural magnetic reso-
nance images [28]. Before segmentation into gray and
white matter segments, the anterior commissure was
manually defined. Images were then normalized, bias field
corrected, and tissue classified. Subsequently, analyses
were performed on GM segments resulted in the DARTEL
(Diffeomorphic Anatomical Registration Through Expo-
nentiated Lie Algebra) analysis, which were multiplied by
the non-linear components derived from the normaliza-
tion matrix in order to preserve actual GM values locally.
This procedure allows for comparing the absolute amount
of tissue corrected for individual brain sizes. The rationale
behind DARTEL is to increase the accuracy of inter-sub-
ject alignment by modeling the shape of each brain using
millions of parameters (three parameters for each voxel).
This procedure has been shown to improve the parame-
terization of brain shapes [71]. Images were smoothed
with an 8 mm full-width at half-maximum (FWHM) iso-
tropic Gaussian kernel to make the data more normally
distributed and to compensate for the inexact nature of
spatial normalization. By applying independent t-tests we
examined differences of demographic data and clinical
variables between patients suffering from GTS and healthy
controls. An ANOVA was conducted to calculate voxel-
wise GM differences. To avoid possible edge effects
between different tissue types, we excluded all voxels with
values of less than 0.1 (absolute threshold masking). Cor-
relations of gray matter parameter estimates of patients
with clinical scores were calculated using multiple regres-
sion models in SPM8. Statistical outcomes were corrected
Wittfoth et al. BMC Neuroscience 2012, 13:17
http://www.biomedcentral.com/1471-2202/13/17
Page 8 of 10for multiple comparisons using an empirically determined
extent threshold at an uncorrected p < 0.001. This method
is implemented in SPM8 and refers to the estimated
smoothness of the images. After determining of the num-
ber of resels, the expected Euler characteristic is calcu-
lated. This is used to give the correct threshold (number
o fv o x e l s )t h a ti sr e q u i r e dt oc o n t r o lf o rf a l s ep o s i t i v e
results.
Resulting parameter estimates were extracted from
significant clusters and scaled to the global mean with
the REX toolbox http://web.mit.edu/swg/software.htm.
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